| Code | 51831 | ||||||||||
| MA number | 44/0352/08-S | ||||||||||
| Product Form: | tbl flm 30x2,5 mg (blis. PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.07.2008 |
| SPC: |
SPC_Letrozol STADA 2,5 mg/ml_12/2019.doc.docx
|
| PIL: |
PIL_Letrozol STADA 2,5 mg filmom obalené tablety_08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 29.05.2018 |
